Vaxart, Inc. (VXRT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 1.0800 |
| Open | 1.0700 |
| Bid | 1.0800 x 1300 |
| Ask | 1.1100 x 4000 |
| Day's range | 1.0650 - 1.1300 |
| 52-week range | 0.7300 - 5.4300 |
| Volume | |
| Avg. volume | 3,405,319 |
| Market cap | 145.686M |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 09 Nov 2012 |
| 1y target est | N/A |
- Zacks
Profound Medical (PROF) Surges 5.1%: Is This an Indication of Further Gains?
Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Simply Wall St.
Vaxart Third Quarter 2022 Earnings: US$0.23 loss per share (vs US$0.14 loss in 3Q 2021)
Vaxart ( NASDAQ:VXRT ) Third Quarter 2022 Results Key Financial Results Net loss: US$29.3m (loss widened by 67% from 3Q...
- Zacks
VAXART, INC. (VXRT) Reports Q3 Loss, Misses Revenue Estimates
VAXART, INC. (VXRT) delivered earnings and revenue surprises of 4.17% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
